Co-expression of E and M genes predicts poor breast cancer patient survival.
- Anne Grosse-Wilde (746595)
- Aymeric Fouquier d’Hérouël (746596)
- Ellie McIntosh (746597)
- Gökhan Ertaylan (5663716)
- Alexander Skupin (244450)
- Rolf E. Kuestner (412283)
- Antonio del Sol (19263)
- Kathie-Anne Walters (17799)
- Sui Huang (10384)
Publication date
May 2015
DOIAbstract
<p>Kaplan-Meier plots showing time of overall survival (OS) and relapse-free survival (RFS) of breast cancer patients with different intrinsic breast cancer subtypes using the indicated gene expression signatures consisting of 60 genes (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0126522#pone.0126522.s009" target="_blank">S2 Table</a>) and the Kaplan-Meier-Plotter online tool (database 2014). Numbers of patients within tumor subtype for OS or RFS are indicated on top. Hazard ratio (HR) and respective logrank p-values (P) that discriminate high (red line) and low (black line) expressing patient groups are shown.</p
Add to ORKG